Uganda program aims to stop heart disease in its tracks

NCT ID NCT05783375

Recruiting now Disease control Sponsor: Children's Hospital Medical Center, Cincinnati Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at a program called ADUNU, which aims to find and treat people with rheumatic heart disease in two districts of Uganda. The program uses portable ultrasound to screen for the disease and a registry to keep patients on preventive medication. Researchers will check how many people are reached, stay in care, and follow treatment, as well as the program's costs and how well it works in real-world clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this program could improve screening and treatment adherence for rheumatic heart disease in Uganda, reducing complications and deaths.
What could go wrong: This is an observational study, not a clinical trial of a new drug or device. Results may not apply to other regions or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATIC HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatic heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATIC HEART DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Uganda Heart Institute
RECRUITING

Kampala, Uganda, Uganda

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.